why choose us

First received: November 28, 2023

Clinical Trial: Low Dose Atropine for Symptomatic Vitreous Floaters

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Vitreous Floaters

Study Type: INTERVENTIONAL


Official Title: Low Dose Atropine For Symptomatic Vitreous Floaters

Brief Summary: The objective of this study is to identify a potential pharmacologic option by assessing whether 0.01% atropine may be effective for treating bothersome floaters as measured by scores on a modified NEI VFQ-25.

Read more